# Serum NGAL IN Patients With Multiple Myeloma

> **NCT05439538** · — · UNKNOWN · sponsor: **Assiut University** · enrollment: 60 (estimated)

## Conditions studied

- Multiple Myeloma(MM)

## Interventions

- **DIAGNOSTIC_TEST:** SERUM NGAL

## Key facts

- **NCT ID:** NCT05439538
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-10-01
- **Primary completion:** 2024-10-01
- **Final completion:** 2025-01-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2022-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05439538

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05439538, "Serum NGAL IN Patients With Multiple Myeloma". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT05439538. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*